Prescription Search Support
1.0.0 - STU1
Prescription Search Support
1.0.0 - STU1
Prescription Search Support, published by eHealth Platform Belgium. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-be/pss/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "getrecommendations-a-response",
"meta" : {
"profile" : [
🔗 "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSResponseBundle"
]
},
"identifier" : {
"value" : "response1"
},
"type" : "collection",
"timestamp" : "2025-02-20T00:00:00Z",
"entry" : [
{
"fullUrl" : "urn:uuid:30551ce1-5a28-4356-b684-1e639094ad21",
"resource" : {
"resourceType" : "RequestGroup",
"id" : "getrecommendations-a-response-group",
"meta" : {
"profile" : [
🔗 "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSResponseRequestGroup"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RequestGroup_getrecommendations-a-response-group\"> </a><p class=\"res-header-id\"><b>Generated Narrative: RequestGroup getrecommendations-a-response-group</b></p><a name=\"getrecommendations-a-response-group\"> </a><a name=\"hcgetrecommendations-a-response-group\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PSSResponseRequestGroup.html\">PSS Response Request Group</a></p></div><p><b>status</b>: Active</p><p><b>intent</b>: Proposal</p><p><b>subject</b>: <a href=\"Patient-30551ce1-5a28-4356-b684-2e639094ad48.html\"> Female, DoB Unknown</a></p><blockquote><p><b>action</b></p><h3>Documentations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Label</b></td><td><b>Url</b></td></tr><tr><td style=\"display: none\">*</td><td>Documentation</td><td>Meer details op de BCFI site</td><td><a href=\"https://bcfi.be/nl/chapters/12?frag=8001869\">https://bcfi.be/nl/chapters/12?frag=8001869</a></td></tr><tr><td style=\"display: none\">*</td><td>Documentation</td><td>Plus de details sur le site CBIP</td><td><a href=\"https://cbip.be/fr/chapters/12?frag=8001869\">https://cbip.be/fr/chapters/12?frag=8001869</a></td></tr><tr><td style=\"display: none\">*</td><td>Documentation</td><td>Download het beslismodel van EBPNET</td><td><a href=\"https://ebpnet.be/nl/pss-vaginitis\">https://ebpnet.be/nl/pss-vaginitis</a></td></tr><tr><td style=\"display: none\">*</td><td>Documentation</td><td>Télécharger le modèle de décision d'EBPNET</td><td><a href=\"https://ebpnet.be/fr/pss-vaginite\">https://ebpnet.be/fr/pss-vaginite</a></td></tr></table><p><b>selectionBehavior</b>: At Most One</p><h3>Actions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Extension</b></td><td><b>TextEquivalent</b></td><td><b>Resource</b></td></tr><tr><td style=\"display: none\">*</td><td/><td>Algemeen advies</td><td><a href=\"CommunicationRequest-30551ce1-5a28-4356-b684-1e639094dd22.html\">CommunicationRequest: status = active</a></td></tr><tr><td style=\"display: none\">*</td><td/><td>Metronidazol Oraal</td><td><a href=\"MedicationRequest-30551ce1-5a28-4356-b684-1e639094ac23.html\">MedicationRequest: status = active; intent = proposal; medication[x] = metronidazole</a></td></tr><tr><td style=\"display: none\">*</td><td/><td>Clindamycin local</td><td><a href=\"MedicationRequest-30551ce1-5a28-4356-b684-1e639094ad24.html\">MedicationRequest: status = active; intent = proposal; medication[x] = clindamycin</a></td></tr><tr><td style=\"display: none\">*</td><td/><td>Fluconazol Oraal</td><td><a href=\"MedicationRequest-30551ce1-5a28-4356-b684-1e639094ad26.html\">MedicationRequest: status = active; intent = proposal; medication[x] = </a></td></tr><tr><td style=\"display: none\">*</td><td/><td>Miconazol lokaal</td><td><a href=\"MedicationRequest-30551ce1-5a28-4356-b684-1e639094ad29.html\">MedicationRequest: status = active; intent = proposal; medication[x] = </a></td></tr></table></blockquote></div>"
},
"status" : "active",
"intent" : "proposal",
"subject" : {
🔗 "reference" : "Patient/30551ce1-5a28-4356-b684-2e639094ad48"
},
"action" : [
{
"documentation" : [
{
"type" : "documentation",
"label" : "Meer details op de BCFI site",
"_label" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/language",
"valueCode" : "nl-BE"
}
]
},
"url" : "https://bcfi.be/nl/chapters/12?frag=8001869"
},
{
"type" : "documentation",
"label" : "Plus de details sur le site CBIP",
"_label" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/language",
"valueCode" : "fr-BE"
}
]
},
"url" : "https://cbip.be/fr/chapters/12?frag=8001869"
},
{
"type" : "documentation",
"label" : "Download het beslismodel van EBPNET",
"_label" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/language",
"valueCode" : "nl-BE"
}
]
},
"url" : "https://ebpnet.be/nl/pss-vaginitis"
},
{
"type" : "documentation",
"label" : "Télécharger le modèle de décision d'EBPNET",
"_label" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/language",
"valueCode" : "fr-BE"
}
]
},
"url" : "https://ebpnet.be/fr/pss-vaginite"
}
],
"selectionBehavior" : "at-most-one",
"action" : [
{
"extension" : [
{
"extension" : [
{
"url" : "ratingType",
"valueCode" : "overall"
},
{
"url" : "ratingValue",
"valueRatio" : {
"numerator" : {
"value" : 3
},
"denominator" : {
"value" : 3
}
}
},
{
"url" : "ratingText",
"valueMarkdown" : "Over het algemeen aangewezen",
"_valueMarkdown" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Généralement approprié"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
],
"url" : "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSStructuredRating"
}
],
"textEquivalent" : "Algemeen advies",
"_textEquivalent" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Conseil général"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"resource" : {
🔗 "reference" : "CommunicationRequest/30551ce1-5a28-4356-b684-1e639094dd22"
}
},
{
"extension" : [
{
"extension" : [
{
"url" : "ratingType",
"valueCode" : "overall"
},
{
"url" : "ratingValue",
"valueRatio" : {
"numerator" : {
"value" : 3
},
"denominator" : {
"value" : 3
}
}
},
{
"url" : "ratingText",
"valueMarkdown" : "Over het algemeen aangewezen",
"_valueMarkdown" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Généralement approprié"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
],
"url" : "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSStructuredRating"
}
],
"textEquivalent" : "Metronidazol Oraal",
"_textEquivalent" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Métronidazole orale"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"resource" : {
🔗 "reference" : "MedicationRequest/30551ce1-5a28-4356-b684-1e639094ac23"
}
},
{
"extension" : [
{
"extension" : [
{
"url" : "ratingType",
"valueCode" : "overall"
},
{
"url" : "ratingValue",
"valueRatio" : {
"numerator" : {
"value" : 3
},
"denominator" : {
"value" : 3
}
}
},
{
"url" : "ratingText",
"valueMarkdown" : "Over het algemeen aangewezen",
"_valueMarkdown" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Généralement approprié"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
],
"url" : "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSStructuredRating"
}
],
"textEquivalent" : "Clindamycin local",
"_textEquivalent" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Clindamycine localement"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"resource" : {
🔗 "reference" : "MedicationRequest/30551ce1-5a28-4356-b684-1e639094ad24"
}
},
{
"extension" : [
{
"extension" : [
{
"url" : "ratingType",
"valueCode" : "overall"
},
{
"url" : "ratingValue",
"valueRatio" : {
"numerator" : {
"value" : 1
},
"denominator" : {
"value" : 3
}
}
},
{
"url" : "ratingText",
"valueMarkdown" : "Niet aangewezen",
"_valueMarkdown" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Pas approprié"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
],
"url" : "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSStructuredRating"
}
],
"textEquivalent" : "Fluconazol Oraal",
"_textEquivalent" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Fluconazole orale"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"resource" : {
🔗 "reference" : "MedicationRequest/30551ce1-5a28-4356-b684-1e639094ad26"
}
},
{
"extension" : [
{
"extension" : [
{
"url" : "ratingType",
"valueCode" : "overall"
},
{
"url" : "ratingValue",
"valueRatio" : {
"numerator" : {
"value" : 1
},
"denominator" : {
"value" : 3
}
}
},
{
"url" : "ratingText",
"valueMarkdown" : "Niet aangewezen",
"_valueMarkdown" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Pas approprié"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
],
"url" : "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSStructuredRating"
}
],
"textEquivalent" : "Miconazol lokaal",
"_textEquivalent" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Miconazole localement"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"resource" : {
🔗 "reference" : "MedicationRequest/30551ce1-5a28-4356-b684-1e639094ad29"
}
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:30551ce1-5a28-4356-b684-1e639094dd22",
"resource" : {
"resourceType" : "CommunicationRequest",
"id" : "30551ce1-5a28-4356-b684-1e639094dd22",
"meta" : {
"profile" : [
🔗 "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSResponseCommunicationRequest"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"CommunicationRequest_30551ce1-5a28-4356-b684-1e639094dd22\"> </a><p class=\"res-header-id\"><b>Generated Narrative: CommunicationRequest 30551ce1-5a28-4356-b684-1e639094dd22</b></p><a name=\"30551ce1-5a28-4356-b684-1e639094dd22\"> </a><a name=\"hc30551ce1-5a28-4356-b684-1e639094dd22\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PSSResponseCommunicationRequest.html\">PSS Response Communication Request</a></p></div><p><b>status</b>: Active</p><p><b>subject</b>: <a href=\"Patient-30551ce1-5a28-4356-b684-2e639094ad48.html\"> Female, DoB Unknown</a></p><h3>Payloads</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Content[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><code>Markdown: </code><div><p>Antibioticum behandeling enkel bij storende klachten of bij verhoogd risico op vroeggeboorte. Metronidazol en clindamycine worden in de SKP afgeraden in het eerste trimester. De klinische gegevens omtrent gebruik tijdens het eerste trimester van de zwangerschap zijn nochtans geruststellend en de meeste bronnen geven aan dat het kan gebruikt worden.</p>\n</div></td></tr></table></div>"
},
"status" : "active",
"subject" : {
🔗 "reference" : "Patient/30551ce1-5a28-4356-b684-2e639094ad48"
},
"payload" : [
{
"_contentString" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/rendering-markdown",
"valueMarkdown" : "Antibioticum behandeling enkel bij storende klachten of bij verhoogd risico op vroeggeboorte. Metronidazol en clindamycine worden in de SKP afgeraden in het eerste trimester. De klinische gegevens omtrent gebruik tijdens het eerste trimester van de zwangerschap zijn nochtans geruststellend en de meeste bronnen geven aan dat het kan gebruikt worden.",
"_valueMarkdown" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "Traitement antibiotique uniquement en cas de symptômes dérangeants ou de risque accru de naissance prématurée. Le RCP déconseille l'utilisation du métronidazole et de la clindamycine pendant le premier trimestre de la grossesse. Les données cliniques concernant leur utilisation pendant le premier trimestre de grossesse sont pourtant rassurantes et la plupart des sources acceptent leur utilisation en période de grossesse."
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
]
}
}
]
}
},
{
"fullUrl" : "urn:uuid:30551ce1-5a28-4356-b684-1e639094ac23",
"resource" : {
"resourceType" : "MedicationRequest",
"id" : "30551ce1-5a28-4356-b684-1e639094ac23",
"meta" : {
"profile" : [
🔗 "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSResponseMedicationRequest"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationRequest_30551ce1-5a28-4356-b684-1e639094ac23\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest 30551ce1-5a28-4356-b684-1e639094ac23</b></p><a name=\"30551ce1-5a28-4356-b684-1e639094ac23\"> </a><a name=\"hc30551ce1-5a28-4356-b684-1e639094ac23\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PSSResponseMedicationRequest.html\">PSS Response Medication Request</a></p></div><p><b>status</b>: Active</p><p><b>intent</b>: Proposal</p><p><b>medication</b>: <span title=\"Codes:{http://www.whocc.no/atc J01XD01}, {https://www.ehealth.fgov.be/standards/fhir/medication/CodeSystem/vmpg 21436}\">metronidazole</span></p><p><b>subject</b>: <a href=\"Patient-30551ce1-5a28-4356-b684-2e639094ad48.html\"> Female, DoB Unknown</a></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: 1000 mg per dag in 2 giften gedurende 7 dagen</p><p><b>timing</b>: 2 per 1 day</p><h3>DoseAndRates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Dose[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>1000 mg</td></tr></table></blockquote></div>"
},
"status" : "active",
"intent" : "proposal",
"medicationCodeableConcept" : {
"coding" : [
{
"system" : "http://www.whocc.no/atc",
"code" : "J01XD01"
},
{
"system" : "https://www.ehealth.fgov.be/standards/fhir/medication/CodeSystem/vmpg",
"code" : "21436"
}
]
},
"subject" : {
🔗 "reference" : "Patient/30551ce1-5a28-4356-b684-2e639094ad48"
},
"dosageInstruction" : [
{
"text" : "1000 mg per dag in 2 giften gedurende 7 dagen",
"_text" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "1000 mg par jour en 2 prises pendant 7 jours"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"timing" : {
"repeat" : {
"boundsDuration" : {
"value" : 7,
"system" : "http://unitsofmeasure.org",
"code" : "d"
},
"frequency" : 2,
"period" : 1,
"periodUnit" : "d"
}
},
"doseAndRate" : [
{
"doseQuantity" : {
"value" : 1000,
"unit" : "mg",
"system" : "http://unitsofmeasure.org"
}
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:30551ce1-5a28-4356-b684-1e639094ad24",
"resource" : {
"resourceType" : "MedicationRequest",
"id" : "30551ce1-5a28-4356-b684-1e639094ad24",
"meta" : {
"profile" : [
🔗 "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSResponseMedicationRequest"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationRequest_30551ce1-5a28-4356-b684-1e639094ad24\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest 30551ce1-5a28-4356-b684-1e639094ad24</b></p><a name=\"30551ce1-5a28-4356-b684-1e639094ad24\"> </a><a name=\"hc30551ce1-5a28-4356-b684-1e639094ad24\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PSSResponseMedicationRequest.html\">PSS Response Medication Request</a></p></div><p><b>status</b>: Active</p><p><b>intent</b>: Proposal</p><p><b>medication</b>: <span title=\"Codes:{http://www.whocc.no/atc G01AA10}\">clindamycin</span></p><p><b>subject</b>: <a href=\"Patient-30551ce1-5a28-4356-b684-2e639094ad48.html\"> Female, DoB Unknown</a></p><h3>DosageInstructions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td>ovule: 100 mg per dag in 1 gift gedurende 3 dagen OF vaginale crème: 2% 5 g per dag in 1 gift gedurende 7 dagen</td></tr></table></div>"
},
"status" : "active",
"intent" : "proposal",
"medicationCodeableConcept" : {
"coding" : [
{
"system" : "http://www.whocc.no/atc",
"code" : "G01AA10"
}
]
},
"subject" : {
🔗 "reference" : "Patient/30551ce1-5a28-4356-b684-2e639094ad48"
},
"dosageInstruction" : [
{
"text" : "ovule: 100 mg per dag in 1 gift gedurende 3 dagen OF vaginale crème: 2% 5 g per dag in 1 gift gedurende 7 dagen",
"_text" : {
"extension" : [
{
"extension" : [
{
"url" : "lang",
"valueCode" : "fr-BE"
},
{
"url" : "content",
"valueString" : "ovule : 100 mg par jour en 1 prise pendant 3 jours OU crème vaginale : 2 % 5 g par jour en 1 prise pendant 7 jours"
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/translation"
}
]
}
}
]
}
},
{
"fullUrl" : "urn:uuid:30551ce1-5a28-4356-b684-1e639094ad26",
"resource" : {
"resourceType" : "MedicationRequest",
"id" : "30551ce1-5a28-4356-b684-1e639094ad26",
"meta" : {
"profile" : [
🔗 "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSResponseMedicationRequest"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationRequest_30551ce1-5a28-4356-b684-1e639094ad26\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest 30551ce1-5a28-4356-b684-1e639094ad26</b></p><a name=\"30551ce1-5a28-4356-b684-1e639094ad26\"> </a><a name=\"hc30551ce1-5a28-4356-b684-1e639094ad26\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PSSResponseMedicationRequest.html\">PSS Response Medication Request</a></p></div><p><b>status</b>: Active</p><p><b>intent</b>: Proposal</p><p><b>medication</b>: <span title=\"Codes:\">Fluconazol</span></p><p><b>subject</b>: <a href=\"Patient-30551ce1-5a28-4356-b684-2e639094ad48.html\"> Female, DoB Unknown</a></p></div>"
},
"status" : "active",
"intent" : "proposal",
"medicationCodeableConcept" : {
"text" : "Fluconazol"
},
"subject" : {
🔗 "reference" : "Patient/30551ce1-5a28-4356-b684-2e639094ad48"
}
}
},
{
"fullUrl" : "urn:uuid:30551ce1-5a28-4356-b684-1e639094ad29",
"resource" : {
"resourceType" : "MedicationRequest",
"id" : "30551ce1-5a28-4356-b684-1e639094ad29",
"meta" : {
"profile" : [
🔗 "https://www.ehealth.fgov.be/standards/fhir/pss/StructureDefinition/PSSResponseMedicationRequest"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationRequest_30551ce1-5a28-4356-b684-1e639094ad29\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest 30551ce1-5a28-4356-b684-1e639094ad29</b></p><a name=\"30551ce1-5a28-4356-b684-1e639094ad29\"> </a><a name=\"hc30551ce1-5a28-4356-b684-1e639094ad29\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PSSResponseMedicationRequest.html\">PSS Response Medication Request</a></p></div><p><b>status</b>: Active</p><p><b>intent</b>: Proposal</p><p><b>medication</b>: <span title=\"Codes:\">Miconazol</span></p><p><b>subject</b>: <a href=\"Patient-30551ce1-5a28-4356-b684-2e639094ad48.html\"> Female, DoB Unknown</a></p></div>"
},
"status" : "active",
"intent" : "proposal",
"medicationCodeableConcept" : {
"text" : "Miconazol"
},
"subject" : {
🔗 "reference" : "Patient/30551ce1-5a28-4356-b684-2e639094ad48"
}
}
}
]
}
IG © 2021+ eHealth Platform Belgium. Package hl7.fhir.be.pss#1.0.0 based on FHIR 4.0.1. Generated 2025-08-13
Links: Table of Contents |
QA Report |
Version History |
